Drug Trial Radar · NCT03973047
Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran
Last checked: Nov 19, 2026Latest source record: Apr 4, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
228
Actual
Start
Jun 17, 2019
Primary completion
Jul 19, 2019
Study completion Jul 20, 2019
Sponsor
- Lead sponsor
- AMAG Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 4, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a Phase 1, randomized study to evaluate the rate of nausea in healthy premenopausal study participants following a single dose of BMT with or without a single 8 mg po dose of Zofran given 30 minutes before BMT dosing.
Conditions
- Nausea
Interventions
BremelanotideDrug
Sterile aqueous solution for injection, provided as an autoinjector pen
ZofranDrug
8 mg tablet (over-encapsulation in a capsule)
PlaceboDrug
capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of treatment-emergent nausea following BMT with or without concomitant use of Zofran.Time frame: 2 Days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
ICON Early Phase Serrvices, LLC
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.